AVANOS MEDICAL, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Avanos Medical, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Avanos Medical, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $4.3M, a 52.2% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.3M -$4.7M -52.2% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $9M +$600K +7.14% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $8.4M +$1.4M +20% Dec 31, 2021 10-K 2023-02-21
Q4 2020 $7M +$3.6M +106% Dec 31, 2020 10-K 2022-02-23
Q4 2019 $3.4M +$100K +3.03% Dec 31, 2019 10-K 2021-02-19
Q4 2018 $3.3M +$2M +154% Dec 31, 2018 10-K 2020-02-25
Q4 2017 $1.3M +$800K +160% Dec 31, 2017 10-K 2019-02-26
Q4 2016 $500K $0 0% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $500K -$300K -37.5% Dec 31, 2015 10-K 2017-02-27
Q4 2014 $800K -$3.5M -81.4% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $4.3M Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.